Clinical Trial Update: Safety Study of Nicotinamide to Treat Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports a completed Phase 1/Phase 2 safety study of nicotinamide for Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Nicotinamide (nicotinamide)

Snippet

Sponsor: University of California, Irvine | Conditions: Alzheimer's Disease | Phase 1, Phase 2 | Status: COMPLETED